Ann: Preliminary Final Report , page-4

The action certainly suggests it. From what I gather the big R&D spend has been completed (of course they will have the R&D maintenance in the future just not as much) and now the fruit has come through. Apparently the systems Global Health provide are broad almost like a one stop shop and the clients like this. Good that they beat their guidance by 10% plus nice to see a bit of revenue growth (10%) also. $800K in cash on the balance sheet which looks healthy too. Good little company just very illiquid but that is changing as more shareholders will come on board. Cash flow is good ROC is high ...